文献速递其他结缔组织病

巨噬细胞来源DNA通过POLR3A/STING/I型干扰素轴诱导系统性硬化症纤维化和血管病变

DNA from macrophages induces fibrosis and vasculopathy through POLR3A/STING/type I interferon axis in systemic sclerosis.
PubMed 文献 · Rheumatology (Oxford) · 2023-01-01

该研究探讨RNA聚合酶IIIA(POLR3A)/I型干扰素在系统性硬化症(SSc)发病中的作用。结果显示SSc患者皮肤和血清中胞质DNA及STING通路增加,巨噬细胞来源DNA通过POLR3A/STING通路激活成纤维细胞和内皮细胞的I型干扰素反应,阻断该轴可改善博来霉素诱导SSc小鼠的纤维化和血管病变。

要点

  • SSc患者皮肤和血清中胞质DNA及STING通路较对照增加
  • 巨噬细胞来源DNA通过POLR3A/STING通路诱导成纤维细胞和内皮细胞I型干扰素反应
  • 阻断POLR3A/STING轴可改善博来霉素诱导SSc小鼠的纤维化和血管病变

核心结论

  • SSc表现为DNA泄漏增加和STING通路激活
  • 巨噬细胞来源DNA通过POLR3A/STING通路诱导成纤维细胞和内皮细胞的I型干扰素特征
  • 阻断POLR3A/STING轴为SSc提供了新的治疗靶点

研究设计与样本

  • 检测SSc患者皮肤或血清中胞质DNA和STING通路
  • 将人巨噬细胞DNA转染至SSc成纤维细胞或人脐静脉内皮细胞(HUVECs)
  • 在博来霉素(BLM)诱导的SSc小鼠中评估STING敲除或H151的作用

主要发现

  • SSc患者皮肤中胞质DNA、STING与α-SMA或CD31的共定位以及血清中STING通路均增加
  • 巨噬细胞来源DNA刺激POLR3A从细胞核转位至STING附近的核周区域
  • 巨噬细胞来源DNA激活成纤维细胞/HUVECs中POLR3A/STING/I型干扰素反应、单核细胞黏附和MCP-1表达以及成纤维细胞胶原过度产生
  • 活化的IRF3结合至MCP-1启动子
  • STING缺陷或H151给药在体外和BLM诱导SSc小鼠中均改善纤维化和血管病变

临床怎么用

  • 原文未据此给出推荐

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To clarify the role of RNA polymerase III A (POLR3A)/type I IFN in the pathogenesis of SSc. METHODS: Cytosolic DNA and stimulator of IFN genes (STING) pathway in skin or serum of SSc patients were detected by immunofluorescence, immunohistochemistry and western blotting. DNA from human macrophages was transfected to SSc fibroblasts or human umbilical vein endothelial cells (HUVECs) and then markers of POLR3A/STING pathway were detected by real-time qPCR, western blotting and confocal microscopy. After H151 treatment or knocking down POLR3A/STING, type I IFN response, monocytes adhesion and activation of fibroblasts and HUVECs were evaluated. Regulation of IFN regulatory factor 3 (IRF3) on monocyte chemoattractant protein-1 (MCP-1) was determined by chromatin immunoprecipitation. In bleomycin (BLM)-induced SSc mice, the effect of STING knockout or H151 on vasculopathy and fibrosis was assessed. RESULTS: Cytosolic DNA, colocalization of STING with alpha-smooth muscle actin (α-SMA) or CD31 in the skin, and STING pathway in the serum of SSc patients were increased. Macrophage-derived DNA stimulated the translocation of POLR3A from nucleus to the perinuclear region near STING and activated POLR3A/STING/type I IFN response, monocytes adhesion and MCP-1 expression in fibroblasts/HUVECs and collagen overproduction of fibroblasts. The activated IRF3 bound to the promoter of MCP-1. STING deficiency or H151 administration ameliorated fibrosis and vasculopathy both in vitro and in BLM-induced SSc mice. CONCLUSIONS: SSc presented increased DNA leakage and STING pathway activation. DNA from macrophages induced type I IFN signature of fibroblasts and ECs through POLR3A/STING pathway. Blocking POLR3A/STING axis provides a new therapeutic target for SSc.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Liu C, Tang J, Luo W, et al. DNA from macrophages induces fibrosis and vasculopathy through POLR3A/STING/type I interferon axis in systemic sclerosis. Rheumatology (Oxford). 2023. PMID: 35686918. doi:10.1093/rheumatology/keac324

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。